Panacea Index Logo

Command Palette

Search for a command to run...

Non-pharmacological treatment for depressed older patients in primary care: A systematic review and meta-analysis.

PloS one
January 1, 2017
Floor Holvast et al. (4 authors)
Journal ArticleMeta-AnalysisReviewSystematic ReviewHuman Study
Study Details

Study Goal

The researchers aimed to evaluate the effectiveness of non-pharmacological treatments, including bright-light therapy, for late-life depression in primary care settings.

Results Summary

The study found that bright-light therapy was effective for late-life depression, with one study showing positive results, though the overall meta-analysis focused primarily on cognitive behavioral therapy.

Population

Adults aged 60 years or older with late-life depression in primary care and community settings.

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
cognitive behavioral therapy
decrease
late-life depression
adults aged 60 years or older in primary care
small effect
showed a small effect
#1
bright-light therapy
decrease
late-life depression
adults aged 60 years or older in primary care
-
was effective
#2
bibliotherapy
decrease
late-life depression
adults aged 60 years or older in community setting
-
were effective
#3
life-review
decrease
late-life depression
adults aged 60 years or older in community setting
-
were effective
#4
problem-solving therapy
decrease
late-life depression
adults aged 60 years or older in community setting
-
were effective
#5
cognitive behavioral therapy
decrease
late-life depression
adults aged 60 years or older in community setting
-
were effective
#6
Abstract

BACKGROUND: Late-life depression is most often treated in primary care, and it usually coincides with chronic somatic diseases. Given that antidepressants contribute to polypharmacy in these patients, and potentially to interactions with other drugs, non-pharmacological treatments are essential. In this systematic review and meta-analysis, we aimed to present an overview of the non-pharmacological treatments available in primary care for late-life depression. METHOD: The databases of PubMed, PsychINFO, and the Cochrane Central Register of Controlled Trials were systematically searched in January 2017 with combinations of MeSH-terms and free text words for "general practice," "older adults," "depression," and "non-pharmacological treatment". All studies with empirical data concerning adults aged 60 years or older were included, and the results were stratified by primary care, and community setting. We narratively reviewed the results and performed a meta-analysis on cognitive behavioral therapy in the primary care setting. RESULTS: We included 11 studies conducted in primary care, which covered the following five treatment modalities: cognitive behavioral therapy, exercise, problem-solving therapy, behavioral activation, and bright-light therapy. Overall, the meta-analysis showed a small effect for cognitive behavioral therapy, with one study also showing that bright-light therapy was effective. Another 18 studies, which evaluated potential non-pharmacological interventions in the community suitable for implementation, indicated that bibliotherapy, life-review, problem-solving therapy, and cognitive behavioral therapy were effective at short-term follow-up. DISCUSSION: We conclude that the effects of several treatments are promising, but need to be replicated before they can be implemented more widely in primary care. Although more treatment modalities were effective in a community setting, more research is needed to investigate whether these treatments are also applicable in primary care. TRIAL REGISTRATION: PROSPERO CRD42016038442.

Medical Subject Headings (MeSH)
AgedAged, 80 and overDepressionHumansMiddle AgedPrimary Health Care
Study Links
Quality Scores
SafetyNot Assessed
Efficacy70/10
Quality80/10
Citation Metrics
Total Citations45
Citations/Year5.6
Relative Citation Ratio2.73
NIH Percentile82.9%
Research Impact Scores
APT Score0.95
Weight Score2.11
Normalized Score0.64
Related Supplements